Assessing B-cell depletion and disease activity in a french multiple sclerosis cohort treated by long-term anti-CD20 antibody therapy

被引：0
|
作者：
Freeman, S. [1 ]
Lemarchant, B. [1 ,2 ]
Alberto, T. [1 ]
Drelon, A. [1 ]
Boucher, J. [1 ]
Dubucquoi, S. [3 ]
Zephir, H. [1 ,2 ]
机构：
[1] Univ Lille, Dept Neurol, CRC SEP, CHU Lille, Lille, France
[2] Univ Lille, INSERM, CHU Lille, Lille, France
[3] Univ Lille, INSERM, CHU Lille, U1286,INFINITE Institute Translat Res Inflammat, Lille, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P328
引用
收藏
页码：355 / 356
页数：2
相关论文
共 50 条
  • [31] Unraveling the T-B tangle in anti-CD20 multiple sclerosis therapy
    Waisman, Ari
    Ebering, Anna
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (51) : 25376 - 25377
  • [32] Effects of anti-CD20 monoclonal antibody therapy on cerebrospinal fluid B cell subsets in relapsing-remitting multiple sclerosis
    El Mahdaoui, S.
    Hansen, M. M.
    von Essen, M.
    Sellebjerg, F.
    Christensen, J. Romme
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 840 - 840
  • [33] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
  • [34] Anti-CD20 monoclonal antibody as a new treatment modality for B-cell lymphoma
    Hotta, T
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2002, 35 (04) : 275 - 279
  • [35] Microenvironment in Systemic Sclerosis Provides a Protective Niche for Tissue-resident B Cells During B Cell Depletion Therapy with Anti-CD20 Antibody
    Kuzumi, Ai
    Yoshizaki, Ayumi
    Fukasawa, Takemichi
    Ebata, Satoshi
    Asano, Yoshihide
    Sato, Shinichi
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [36] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
    Abou Mourad, Y
    Taber, A
    Chehal, A
    Shamseddine, A
    ANNALS OF HEMATOLOGY, 2004, 83 (05) : 319 - 321
  • [37] Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies
    Fagnano, Ester
    Pendharkar, Swati
    Colton, Madyson
    Jones, Philip N.
    Sallan, Marta Crespi
    Klymenko, Tetyana
    Braun, Andrejs
    Klein, Christian
    Honeychurch, Jamie
    Cheadle, Eleanor J.
    Illidge, Timothy M.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [38] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
    Yasser Abou Mourad
    Ali Taher
    Aref Chehal
    Ali Shamseddine
    Annals of Hematology, 2004, 83 : 319 - 321
  • [39] Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab
    Pickartz, T
    Ringel, F
    Wedde, M
    Renz, H
    Klein, A
    von Neuhoff, N
    Dreger, P
    Kreuzer, KA
    Schmidt, CA
    Srock, S
    Schoeler, D
    Schriever, F
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (12) : 1410 - 1416
  • [40] Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma
    Knox, SJ
    Goris, ML
    Trisler, K
    Negrin, R
    Davis, T
    Liles, TM
    GrilloLopez, A
    Chinn, P
    Varns, C
    Ning, SC
    Fowler, S
    Deb, N
    Becker, M
    Marquez, C
    Levy, R
    CLINICAL CANCER RESEARCH, 1996, 2 (03) : 457 - 470
12345